Pharming Group (PHAR) Earnings Date, Estimates & Call Transcripts → A new way to collect income from stocks (From DTI) (Ad) Free phar Stock Alerts $9.60 -0.23 (-2.34%) (As of 04/25/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 8Before Market OpensConfirmedActual EPS (Mar. 14) -$0.03 Missed By -$0.08 Consensus EPS (Mar. 14) $0.05 Get Pharming Group Earnings AlertsEnter your email address below to receive the latest news and earnings results for PHAR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePHAR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PHAR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Pharming Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.01$0.01$0.01 Q2 20241$0.02$0.02$0.02 Q3 20241$0.00$0.00$0.00 Q4 20241($0.01)($0.01)($0.01) FY 20244$0.02$0.02 $0.02PHAR Earnings Date and InformationPharming Group last released its earnings results on March 14th, 2024. The reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by $0.08. The business earned $81.20 million during the quarter, compared to analyst estimates of $71.83 million. Pharming Group has generated ($0.14) earnings per share over the last year (($0.14) diluted earnings per share). Earnings for Pharming Group are expected to grow in the coming year, from ($0.02) to ($0.01) per share. Pharming Group has confirmed that its next quarterly earnings report will be published on Wednesday, May 8th, 2024. Read More Pharming Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/8/2024Confirmed)------- 3/14/2024Q4 2023$0.05($0.03)($0.08)($0.02)$71.83 million$81.20 million10/26/2023Q3 2023$0.13$0.05($0.08)$0.05$61.67 million$66.66 million8/3/2023Q2 2023($0.02)$0.02+$0.04$0.02$51.80 million$54.90 million5/11/2023Q1 2023($0.01)($0.17)($0.16)($0.17)$48.15 million$42.54 million3/16/2023Q4 2022$0.01($0.19)($0.20)($0.17)$57.94 million$54.62 million10/27/2022Q3 2022$0.02$0.13+$0.11$0.13$53.52 million$54.24 million Get the Latest News and Ratings for PHAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022$0.01$0.04+$0.03($0.14)$51.99 million$50.15 million5/12/2022Q1 2022-$0.05+$0.05$0.05$48.00 million$46.62 million3/17/2022Q4 2021$0.01$0.01-$0.01$57.59 million$52.77 million10/28/2021Q3 2021-($0.04)($0.04)($0.04)-$28.70 million8/5/2021Q2 2021$0.01$0.06+$0.05$0.06$64.13 million$49.60 million5/13/2021Q1 2021$0.01$0.13+$0.12$0.13$60.50 million$43.45 million Pharming Group Earnings - Frequently Asked Questions When is Pharming Group's earnings date? Pharming Group has confirmed that its next quarterly earnings data will be published on Wednesday, May 8th, 2024. Learn more on PHAR's earnings history. Did Pharming Group beat their earnings estimates last quarter? In the previous quarter, Pharming Group (NASDAQ:PHAR) missed the analysts' consensus estimate of $0.05 by $0.08 with a reported earnings per share (EPS) of ($0.03). Learn more on analysts' earnings estimate vs. PHAR's actual earnings. How much revenue does Pharming Group generate each year? Pharming Group (NASDAQ:PHAR) has a recorded annual revenue of $245.32 million. How much profit does Pharming Group generate each year? Pharming Group (NASDAQ:PHAR) has a recorded net income of -$10.55 million. PHAR has generated -$0.14 earnings per share over the last four quarters. What is Pharming Group's EPS forecast for next year? Pharming Group's earnings are expected to grow from ($0.02) per share to ($0.01) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Y-mAbs Therapeutics Earnings Results Praxis Precision Medicines Earnings Results Bicycle Therapeutics Earnings Results Aerovate Therapeutics Earnings Results Longboard Pharmaceuticals Earnings Results Savara Earnings Results ORIC Pharmaceuticals Earnings Results Silence Therapeutics Earnings Results SIGA Technologies Earnings Results Nurix Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:PHAR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
